{ "Version": 80, "ExpressionProfiles": [ { "Type": "Enzyme", "Species": "Human", "Molecule": "CYP3A4", "Category": "Healthy", "Parameters": [ { "Path": "CYP3A4|Reference concentration", "Value": 4.32, "Unit": "µmol/l" }, { "Path": "CYP3A4|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "CYP3A4|t1/2 (liver)", "Value": 36.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Path": "Organism|Brain|Intracellular|CYP3A4|Relative expression", "Value": 0.0041682898325 }, { "Path": "Organism|Gonads|Intracellular|CYP3A4|Relative expression", "Value": 0.00078691079081 }, { "Path": "Organism|Kidney|Intracellular|CYP3A4|Relative expression", "Value": 0.0053603428126 }, { "Path": "Organism|Liver|Pericentral|Intracellular|CYP3A4|Relative expression", "Value": 1.0 }, { "Path": "Organism|Liver|Periportal|Intracellular|CYP3A4|Relative expression", "Value": 1.0 }, { "Path": "Organism|Lung|Intracellular|CYP3A4|Relative expression", "Value": 0.00042695753798 }, { "Path": "Organism|SmallIntestine|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 } ], "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome", "Ontogeny": { "Name": "CYP3A4" } }, { "Type": "Transporter", "Species": "Human", "Molecule": "OATP1B1", "Category": "Healthy", "Parameters": [ { "Path": "OATP1B1|Reference concentration", "Value": 1.0, "Unit": "µmol/l" }, { "Path": "OATP1B1|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "OATP1B1|t1/2 (liver)", "Value": 36.0, "Unit": "h" }, { "Path": "Organism|Brain|Intracellular|OATP1B1|Relative expression", "Value": 0.00014166666667 }, { "Path": "Organism|Gonads|Intracellular|OATP1B1|Relative expression", "Value": 0.0141666667 }, { "Path": "Organism|Heart|Intracellular|OATP1B1|Relative expression", "Value": 0.0008253968254 }, { "Path": "Organism|Liver|Pericentral|Intracellular|OATP1B1|Relative expression", "Value": 1.0 }, { "Path": "Organism|Liver|Periportal|Intracellular|OATP1B1|Relative expression", "Value": 1.0 }, { "Path": "Organism|Lung|Intracellular|OATP1B1|Relative expression", "Value": 4.0079365079E-05 }, { "Path": "Organism|Muscle|Intracellular|OATP1B1|Relative expression", "Value": 0.00064682539683 } ], "TransportType": "Influx", "Expression": [ { "Name": "Bone", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Brain", "TransportDirection": "InfluxBrainPlasmaToInterstitial", "CompartmentName": "Plasma" }, { "Name": "Brain", "TransportDirection": "InfluxBrainInterstitialToTissue", "CompartmentName": "Interstitial" }, { "Name": "Fat", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Gonads", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Heart", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Kidney", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "Kidney", "TransportDirection": "ExcretionKidney", "CompartmentName": "Intracellular" }, { "Name": "Stomach", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "SmallIntestine", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Duodenum", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "Duodenum", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "UpperJejunum", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "UpperJejunum", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "LowerJejunum", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "LowerJejunum", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "UpperIleum", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "UpperIleum", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "LowerIleum", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "LowerIleum", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "LargeIntestine", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Caecum", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "Caecum", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "ColonAscendens", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "ColonAscendens", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "ColonTransversum", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "ColonTransversum", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "ColonDescendens", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "ColonDescendens", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "ColonSigmoid", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "ColonSigmoid", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Rectum", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "Rectum", "TransportDirection": "InfluxLumenToMucosaIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Periportal", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "Periportal", "TransportDirection": "ExcretionLiver", "CompartmentName": "Intracellular" }, { "Name": "Pericentral", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Interstitial" }, { "Name": "Pericentral", "TransportDirection": "ExcretionLiver", "CompartmentName": "Intracellular" }, { "Name": "Lung", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Muscle", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Pancreas", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Skin", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "Spleen", "TransportDirection": "InfluxInterstitialToIntracellular", "CompartmentName": "Intracellular" }, { "Name": "BloodCells", "TransportDirection": "InfluxPlasmaToBloodCells" }, { "Name": "VascularEndothelium", "TransportDirection": "InfluxPlasmaToInterstitial" } ] }, { "Type": "Enzyme", "Species": "Human", "Molecule": "CYP2B6", "Category": "Healthy", "Parameters": [ { "Path": "CYP2B6|Reference concentration", "Value": 1.56, "Unit": "µmol/l" }, { "Path": "CYP2B6|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "CYP2B6|t1/2 (liver)", "Value": 32.0, "Unit": "h" }, { "Path": "Organism|Brain|Intracellular|CYP2B6|Relative expression", "Value": 0.0021211129296 }, { "Path": "Organism|Gonads|Intracellular|CYP2B6|Relative expression", "Value": 0.0063502454992 }, { "Path": "Organism|Kidney|Intracellular|CYP2B6|Relative expression", "Value": 0.1043535188 }, { "Path": "Organism|Liver|Pericentral|Intracellular|CYP2B6|Relative expression", "Value": 1.0 }, { "Path": "Organism|Liver|Periportal|Intracellular|CYP2B6|Relative expression", "Value": 1.0 }, { "Path": "Organism|Lung|Intracellular|CYP2B6|Relative expression", "Value": 0.5970540098 }, { "Path": "Organism|SmallIntestine|Intracellular|CYP2B6|Relative expression", "Value": 0.0703109656 }, { "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP2B6|Relative expression", "Value": 0.0703109656 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP2B6|Relative expression", "Value": 0.0703109656 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP2B6|Relative expression", "Value": 0.0703109656 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP2B6|Relative expression", "Value": 0.0703109656 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP2B6|Relative expression", "Value": 0.0703109656 } ], "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome" }, { "Type": "Enzyme", "Species": "Human", "Molecule": "UGT2B7", "Category": "Healthy", "Parameters": [ { "Path": "Organism|Gonads|Intracellular|UGT2B7|Relative expression", "Value": 0.00094468085106 }, { "Path": "Organism|LargeIntestine|Intracellular|UGT2B7|Relative expression", "Value": 0.0049787234043 }, { "Path": "Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|UGT2B7|Relative expression", "Value": 0.0049787234043 }, { "Path": "Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|UGT2B7|Relative expression", "Value": 0.0049787234043 }, { "Path": "Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|UGT2B7|Relative expression", "Value": 0.0049787234043 }, { "Path": "Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|UGT2B7|Relative expression", "Value": 0.0049787234043 }, { "Path": "Organism|Liver|Pericentral|Intracellular|UGT2B7|Relative expression", "Value": 1.0 }, { "Path": "Organism|Liver|Periportal|Intracellular|UGT2B7|Relative expression", "Value": 1.0 }, { "Path": "Organism|Pancreas|Intracellular|UGT2B7|Relative expression", "Value": 0.0354468085 }, { "Path": "Organism|SmallIntestine|Intracellular|UGT2B7|Relative expression", "Value": 0.5361702128 }, { "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|UGT2B7|Relative expression", "Value": 0.5361702128 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|UGT2B7|Relative expression", "Value": 0.5361702128 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|UGT2B7|Relative expression", "Value": 0.5361702128 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|UGT2B7|Relative expression", "Value": 0.5361702128 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|UGT2B7|Relative expression", "Value": 0.5361702128 }, { "Path": "UGT2B7|Reference concentration", "Value": 3.372, "Unit": "µmol/l", "ValueOrigin": { "Source": "Publication", "Description": "Ohtsuki et al. 2011" } }, { "Path": "UGT2B7|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "UGT2B7|t1/2 (liver)", "Value": 36.0, "Unit": "h" } ], "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome", "Ontogeny": { "Name": "UGT2B7" } } ], "Individuals": [ { "Name": "Barzaghi1987", "Seed": 1877189984, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 24.0, "Unit": "year(s)" }, "Weight": { "Value": 70.0, "Unit": "kg" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "CYP3A4|Human|Healthy", "OATP1B1|Human|Healthy", "CYP2B6|Human|Healthy", "UGT2B7|Human|Healthy" ] }, { "Name": "Wong1983", "Seed": 1892668203, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "WhiteAmerican_NHANES_1997", "Gender": "MALE", "Age": { "Value": 30.0, "Unit": "year(s)" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "CYP3A4|Human|Healthy", "OATP1B1|Human|Healthy", "CYP2B6|Human|Healthy", "UGT2B7|Human|Healthy" ] }, { "Name": "Miles1989", "Seed": 1741296282, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "WhiteAmerican_NHANES_1997", "Gender": "MALE", "Age": { "Value": 25.4, "Unit": "year(s)" }, "Weight": { "Value": 78.8, "Unit": "kg" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "CYP3A4|Human|Healthy", "OATP1B1|Human|Healthy", "CYP2B6|Human|Healthy", "UGT2B7|Human|Healthy" ] } ], "Compounds": [ { "Name": "Carbamazepine", "IsSmallMolecule": true, "PlasmaProteinBindingPartner": "Albumin", "Lipophilicity": [ { "Name": "Optimized", "Parameters": [ { "Name": "Lipophilicity", "Value": 2.0067753065, "Unit": "Log Units", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '001-5-3_CYP3A4_MM-kinetics_WithoutTablet' on 2022-02-21 16:49" } } ] } ], "FractionUnbound": [ { "Name": "Morselli 1975", "Species": "Human", "Parameters": [ { "Name": "Fraction unbound (plasma, reference value)", "Value": 0.243, "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "Morselli 1975" } } ] } ], "Solubility": [ { "Name": "IR tablet (FaHIF)", "Parameters": [ { "Name": "Solubility at reference pH", "Value": 308.3333, "Unit": "mg/l", "ValueOrigin": { "Source": "Publication", "Method": "InVivo", "Description": "Mean value of the following FaHIF solubility data reported in the literature: 336 µg/mL, pH 6.2 (Annaert 2010); 283 µg/mL, pH 7.0 (Söderlind 2010); 306 mg/mL, pH 6.9 (Clarysse 2011)" } }, { "Name": "Reference pH", "Value": 6.7, "ValueOrigin": { "Source": "Publication", "Method": "InVivo", "Description": "Mean value of the following FaHIF solubility data reported in the literature: 336 µg/mL, pH 6.2 (Annaert 2010); 283 µg/mL, pH 7.0 (Söderlind 2010); 306 mg/mL, pH 6.9 (Clarysse 2011)" } } ] }, { "Name": "XR tablet (fitted)", "IsDefault": false, "Parameters": [ { "Name": "Solubility at reference pH", "Value": 546.0199756643, "Unit": "mg/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '004-2_from-003-1_XRtablet_fasted_solubility_FINAL' on 2022-03-24 12:41" } }, { "Name": "Reference pH", "Value": 6.7, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '004-2_from-003-1_XRtablet_fasted_solubility_FINAL' on 2022-03-16 18:25" } } ] } ], "PkaTypes": [ { "Type": "Acid", "Pka": 11.83, "ValueOrigin": { "Source": "Publication", "Description": "Tomaszewska 2013" } } ], "Processes": [ { "InternalName": "Induction", "DataSource": "DMPK", "Molecule": "CYP3A4", "Parameters": [ { "Name": "EC50", "Value": 27.193363407, "Unit": "µmol/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '003-1_from002-3-6_EC50' on 2022-02-24 10:23" } }, { "Name": "Emax", "Value": 5.3929777775, "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "DMPK measurement, calibrated with rifampicin" } } ] }, { "InternalName": "GlomerularFiltration", "DataSource": "Glomerular Filtration", "Species": "Human", "Parameters": [ { "Name": "GFR fraction", "Value": 0.0240108793, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '002-3-6_from001-5-3_IRtablet-sd_Pint-FIX_FINAL' on 2022-02-23 17:18" } } ] }, { "InternalName": "MetabolizationLiverMicrosomes_MM", "DataSource": "N-Glucuronidation_Staines2004", "Molecule": "UGT2B7", "Parameters": [ { "Name": "In vitro Vmax for liver microsomes", "Value": 3.5, "Unit": "pmol/min/mg mic. protein", "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "Staines 2004" } }, { "Name": "Content of CYP proteins in liver microsomes", "Value": 82.9, "Unit": "pmol/mg mic. protein", "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "Achour et al - 2014" } }, { "Name": "Km", "Value": 234.0, "Unit": "µmol/l", "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "Staines2004" } }, { "Name": "kcat", "Value": 0.0668699322, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '002-3-6_from001-5-3_IRtablet-sd_Pint-FIX_FINAL' on 2022-02-23 17:18" } } ] }, { "InternalName": "MetabolizationLiverMicrosomes_MM", "DataSource": "3-Hydroxylation_Pearce2002", "Molecule": "CYP2B6", "Parameters": [ { "Name": "In vitro Vmax for liver microsomes", "Value": 49.0, "Unit": "pmol/min/mg mic. protein", "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "Pearce et al. 2002" } }, { "Name": "Content of CYP proteins in liver microsomes", "Value": 39.0, "Unit": "pmol/mg mic. protein", "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "Rodrigues 1999" } }, { "Name": "Km", "Value": 235.0, "Unit": "µmol/l", "ValueOrigin": { "Source": "Unknown", "Description": "Pearce 2002" } }, { "Name": "kcat", "Value": 0.9361790504, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '002-3-6_from001-5-3_IRtablet-sd_Pint-FIX_FINAL' on 2022-02-23 17:18" } } ] }, { "InternalName": "MetabolizationLiverMicrosomes_MM", "DataSource": "Epoxidation_Sakamoto2013", "Molecule": "CYP3A4", "Parameters": [ { "Name": "In vitro Vmax for liver microsomes", "Value": 726.0, "Unit": "pmol/min/mg mic. protein", "ValueOrigin": { "Source": "Unknown", "Description": "Sakamoto 2013" } }, { "Name": "Km", "Value": 808.0, "Unit": "µmol/l", "ValueOrigin": { "Source": "Unknown", "Description": "Sakamoto 2013" } }, { "Name": "kcat", "Value": 5.0088763476, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '002-3-6_from001-5-3_IRtablet-sd_Pint-FIX_FINAL' on 2022-02-23 17:18" } } ] }, { "InternalName": "Induction", "DataSource": "Faucette2004", "Molecule": "CYP2B6", "Parameters": [ { "Name": "EC50", "Value": 1000.0, "Unit": "µmol/l" }, { "Name": "Emax", "Value": 148.7284 } ] } ], "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Parameters": [ { "Name": "Molecular weight", "Value": 236.2686, "Unit": "g/mol", "ValueOrigin": { "Source": "Internet", "Description": "DrugBank" } } ] }, { "Name": "Erythromycin", "IsSmallMolecule": true, "Lipophilicity": [ { "Name": "Literature (average value)", "Parameters": [ { "Name": "Lipophilicity", "Value": 2.82, "Unit": "Log Units", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } } ] } ], "FractionUnbound": [ { "Name": "Barre 1987", "Species": "Human", "Parameters": [ { "Name": "Fraction unbound (plasma, reference value)", "Value": 0.305, "ValueOrigin": { "Source": "Publication", "Method": "InVivo", "Description": "PMID: 3606934" } } ] } ], "Solubility": [ { "Name": "Erythromycin stearate film-coated tablet", "Parameters": [ { "Name": "Solubility at reference pH", "Value": 28.0708790976, "Unit": "mg/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '003 - BP conc ratio FIX' on 2019-11-14 14:43" } }, { "Name": "Reference pH", "Value": 7.0, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '001' on 2019-10-01 13:46" } } ] }, { "Name": "Erythromycin base enteric coated pellets", "IsDefault": false, "Parameters": [ { "Name": "Solubility at reference pH", "Value": 500.0, "Unit": "mg/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '001' on 2019-10-01 13:46" } }, { "Name": "Reference pH", "Value": 7.0, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '001' on 2019-10-01 13:46" } } ] }, { "Name": "Erythromycin lactobionate", "IsDefault": false, "Parameters": [ { "Name": "Solubility at reference pH", "Value": 200.0, "Unit": "mg/ml", "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "Hoffhine, Jr Charles E. \"Aqueous soluble salts of erythromycin.\" U.S. Patent 2,761,859, issued September 4, 1956. " } }, { "Name": "Reference pH", "Value": 7.0, "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "Hoffhine, Jr Charles E. \"Aqueous soluble salts of erythromycin.\" U.S. Patent 2,761,859, issued September 4, 1956. " } } ] }, { "Name": "Erythromycin base enteric coated tablet", "IsDefault": false, "Parameters": [ { "Name": "Solubility at reference pH", "Value": 8.3990771997, "Unit": "mg/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "Reference pH", "Value": 7.0 } ] } ], "IntestinalPermeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Specific intestinal permeability (transcellular)", "Value": 0.00038668371665, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } } ] } ], "PkaTypes": [ { "Type": "Base", "Pka": 8.88, "ValueOrigin": { "Source": "Publication", "Method": "Unknown", "Description": "PMID: 9135031" } } ], "Processes": [ { "InternalName": "MetabolizationLiverMicrosomes_MM", "DataSource": "Biotransformation_fitted", "Molecule": "CYP3A4", "Parameters": [ { "Name": "In vitro Vmax for liver microsomes", "Value": 918.33333, "Unit": "pmol/min/mg mic. protein", "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "PMID: 9566442" } }, { "Name": "Km", "Value": 70.0, "Unit": "µM", "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "Average of reported values in the literature (PMID: 9107550 and PMID: 9566442)" } } ] }, { "InternalName": "GlomerularFiltration", "DataSource": "fitted", "Species": "Human", "Parameters": [ { "Name": "GFR fraction", "Value": 1.1591081815, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } } ] }, { "InternalName": "IrreversibleInhibition", "DataSource": "MBI", "Molecule": "CYP3A4", "Parameters": [ { "Name": "kinact", "Value": 0.0296261146, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "K_kinact_half", "Value": 7.6007360452, "Unit": "µmol/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } } ] }, { "InternalName": "ActiveTransportSpecific_MM", "DataSource": "fitted", "Molecule": "OATP1B1", "Parameters": [ { "Name": "Transporter concentration", "Value": 1.0, "Unit": "µmol/l" }, { "Name": "Vmax", "Value": 11.66, "Unit": "pmol/ml/min", "ValueOrigin": { "Source": "Publication", "Method": "InVitro", "Description": "PMID: 22990751" } }, { "Name": "Km", "Value": 0.735836485, "Unit": "µmol/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "kcat", "Value": 1.350032201, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } } ] }, { "InternalName": "LiverClearance", "DataSource": "fitted", "Species": "Human", "Parameters": [ { "Name": "Fraction unbound (experiment)", "Value": 0.305 }, { "Name": "Lipophilicity (experiment)", "Value": 2.48, "Unit": "Log Units" }, { "Name": "Plasma clearance", "Value": 0.0, "Unit": "ml/min/kg" }, { "Name": "Specific clearance", "Value": 4.1462183378, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } } ] } ], "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - Charge dependent Schmitt" ], "Parameters": [ { "Name": "Molecular weight", "Value": 733.927, "Unit": "g/mol", "ValueOrigin": { "Source": "Internet", "Description": "drugbank.ca" } } ] } ], "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "FormulationType": "Formulation_Tablet_Weibull", "Parameters": [ { "Name": "Dissolution time (50% dissolved)", "Value": 109.3089775422, "Unit": "min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '002-3-6_from001-5-3_IRtablet-sd_Pint-FIX_FINAL' on 2022-02-23 17:18" } }, { "Name": "Lag time", "Value": 0.0, "Unit": "min" }, { "Name": "Dissolution shape", "Value": 0.6890123758, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '002-3-6_from001-5-3_IRtablet-sd_Pint-FIX_FINAL' on 2022-02-23 17:18" } }, { "Name": "Use as suspension", "Value": 1.0 } ] }, { "Name": "Erythromycin_Weibull_filmtablet", "FormulationType": "Formulation_Tablet_Weibull", "Parameters": [ { "Name": "Dissolution time (50% dissolved)", "Value": 1.7038947098, "Unit": "min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "Lag time", "Value": 0.0, "Unit": "min", "ValueOrigin": { "Source": "Other", "Method": "Assumption" } }, { "Name": "Dissolution shape", "Value": 1.0960212213, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "Use as suspension", "Value": 1.0 } ] }, { "Name": "Erythromycin_Weibull_filmtablet_250mg", "FormulationType": "Formulation_Tablet_Weibull", "Parameters": [ { "Name": "Dissolution time (50% dissolved)", "Value": 83.6562552486, "Unit": "min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "Lag time", "Value": 0.0, "Unit": "min", "ValueOrigin": { "Source": "Other", "Method": "Assumption" } }, { "Name": "Dissolution shape", "Value": 3.2811974117, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "Use as suspension", "Value": 1.0 } ] }, { "Name": "Erythromycin_Weibull_enteric-coated-pellets", "FormulationType": "Formulation_Tablet_Weibull", "Parameters": [ { "Name": "Dissolution time (50% dissolved)", "Value": 1.7462743767, "Unit": "min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "Lag time", "Value": 54.3490442506, "Unit": "min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "Dissolution shape", "Value": 1.0564916105, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from 'Parameter Identification 1' on 2020-01-13 15:01" } }, { "Name": "Use as suspension", "Value": 1.0 } ] } ], "Protocols": [ { "Name": "Barzaghi1987_ControlPhase", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 400.0, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 357.1, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "NumberOfRepetitions", "Value": 14.0, "ValueOrigin": { "Source": "Unknown" } }, { "Name": "TimeBetweenRepetitions", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "TimeUnit": "h" }, { "Name": "Barzaghi1987_TreatmentPhase_Carbamazepine", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 400.0, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 144.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Barzaghi1987_TreatmentPhase_Erythromycin", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 500.0, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 30.0 }, { "Name": "TimeBetweenRepetitions", "Value": 8.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Wong1983_TreatmentPhase_Erythromycin", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 250.0, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 32.0 }, { "Name": "TimeBetweenRepetitions", "Value": 6.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Wong1983_TreatmentPhase_Carbamazepine", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 400.0, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 120.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Miles 1989 - TreatmentPhase - Carbamazepine 300mg", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 300.0, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "NumberOfRepetitions", "Value": 17.0, "ValueOrigin": { "Source": "Unknown" } }, { "Name": "TimeBetweenRepetitions", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "TimeUnit": "h" }, { "Name": "Miles 1989 - TreatmentPhase - Erythromycin", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 250.0, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 336.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "NumberOfRepetitions", "Value": 12.0, "ValueOrigin": { "Source": "Unknown" } }, { "Name": "TimeBetweenRepetitions", "Value": 6.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "TimeUnit": "h" }, { "Name": "Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 357.1428571429, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "NumberOfRepetitions", "Value": 17.0, "ValueOrigin": { "Source": "Unknown" } }, { "Name": "TimeBetweenRepetitions", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "TimeUnit": "h" }, { "Name": "Miles 1989 - TreatmentPhase - Carbamazepine 400mg", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 400.0, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "NumberOfRepetitions", "Value": 17.0, "ValueOrigin": { "Source": "Unknown" } }, { "Name": "TimeBetweenRepetitions", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "TimeUnit": "h" } ], "Simulations": [ { "Name": "Barzaghi1987_ControlPhase", "Model": "4Comp", "ObservedData": [ "Barzaghi 1987 - Without erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 96.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Barzaghi1987_ControlPhase|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)" ], "Individual": "Barzaghi1987", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Barzaghi1987_ControlPhase", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Barzaghi1987_ControlPhase-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Barzaghi1987_ControlPhase|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } }, { "Name": "Barzaghi 1987 - Without erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)-Carbamazepine-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Barzaghi 1987 - Without erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|Time", "Y": "Barzaghi 1987 - Without erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 7, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Barzaghi1987_400mg_sd_tabIR_fed", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nBarzaghi1987_ControlPhase\n2022-05-09 10:25" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" } ] }, { "Name": "Barzaghi1987_TreatmentPhase", "Model": "4Comp", "ObservedData": [ "Barzaghi 1987 - With erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 8.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 144.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 144.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 146.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 146.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 240.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Barzaghi1987_TreatmentPhase_Carbamazepine|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_16|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_17|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_18|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_19|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_20|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_21|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_22|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_23|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_24|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_25|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_26|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_27|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_28|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_29|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_30|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Barzaghi1987_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Undefined Liver|Reference concentration", "Value": 1.0, "Unit": "µmol/l" }, { "Path": "Undefined Liver|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "Undefined Liver|t1/2 (liver)", "Value": 36.0, "Unit": "h" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)" ], "Individual": "Barzaghi1987", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Barzaghi1987_TreatmentPhase_Carbamazepine", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } }, { "Name": "Erythromycin", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - Charge dependent Schmitt" ], "Alternatives": [ { "AlternativeName": "Erythromycin stearate film-coated tablet", "GroupName": "COMPOUND_SOLUBILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Biotransformation_fitted", "MoleculeName": "CYP3A4" }, { "MoleculeName": "CYP2B6" }, { "MoleculeName": "UGT2B7" }, { "Name": "Total Hepatic Clearance-fitted", "SystemicProcessType": "Hepatic" }, { "Name": "OATP1B1-fitted", "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-fitted", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Barzaghi1987_TreatmentPhase_Erythromycin", "Formulations": [ { "Name": "Erythromycin_Weibull_filmtablet", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Barzaghi1987_TreatmentPhase-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Barzaghi1987_TreatmentPhase|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } }, { "Name": "Barzaghi 1987 - With erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)-Carbamazepine-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Barzaghi 1987 - With erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|Time", "Y": "Barzaghi 1987 - With erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Erythromycin-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Barzaghi1987_TreatmentPhase|Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 2 } } ], "Name": "Barzaghi1987_400mg_sd_tabIR_fed", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nBarzaghi1987_TreatmentPhase\n2022-05-09 10:28" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "Erythromycin" } ] }, { "Name": "Miles1989_ControlPhase_300mg", "Model": "4Comp", "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 408.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_16|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_17|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)" ], "Individual": "Miles1989", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Miles 1989 - TreatmentPhase - Carbamazepine 300mg", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µg/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Miles1989_ControlPhase_300mg-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Miles1989_ControlPhase_300mg|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } } ], "Name": "Miles1989_control_357_md_tabIR", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nMiles1989_ControlPhase_300mg\n2022-05-09 10:32" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" } ] }, { "Name": "Miles1989_ControlPhase_357mg", "Model": "4Comp", "ObservedData": [ "Miles 1989 - CBZ before ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 336.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid|CBZ_tabletIR_fasted (Tegretol)|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)" ], "Individual": "Miles1989", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Miles 1989 - ControlPhase - Carbamazepine 357.1 mg bid", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": 309.0656, "Max": 339.8996, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µg/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 4.742403, "Max": 8.0, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Miles1989_ControlPhase_357mg-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Miles1989_ControlPhase_357mg|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } }, { "Name": "Miles 1989 - CBZ before ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)-Carbamazepine-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Miles 1989 - CBZ before ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|Time", "Y": "Miles 1989 - CBZ before ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Miles1989_control_357_md_tabIR", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nMiles1989_ControlPhase_357mg\n2022-05-09 10:37" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" } ] }, { "Name": "Miles1989_ControlPhase_400mg", "Model": "4Comp", "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 408.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_16|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_17|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)" ], "Individual": "Miles1989", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Miles 1989 - TreatmentPhase - Carbamazepine 400mg", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µg/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Miles1989_ControlPhase_400mg-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Miles1989_ControlPhase_400mg|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } } ], "Name": "Miles1989_control_357_md_tabIR", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nMiles1989_ControlPhase_400mg\n2022-05-09 10:40" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" } ] }, { "Name": "Miles1989_TreatmentPhase_300mg", "Model": "4Comp", "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 408.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_16|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_17|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 300mg|CBZ_tabletIR_fasted (Tegretol)|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Undefined Liver|Reference concentration", "Value": 1.0, "Unit": "µmol/l" }, { "Path": "Undefined Liver|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "Undefined Liver|t1/2 (liver)", "Value": 36.0, "Unit": "h" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)" ], "Individual": "Miles1989", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Miles 1989 - TreatmentPhase - Carbamazepine 300mg", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } }, { "Name": "Erythromycin", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - Charge dependent Schmitt" ], "Alternatives": [ { "AlternativeName": "Erythromycin base enteric coated pellets", "GroupName": "COMPOUND_SOLUBILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Biotransformation_fitted", "MoleculeName": "CYP3A4" }, { "MoleculeName": "CYP2B6" }, { "MoleculeName": "UGT2B7" }, { "Name": "Total Hepatic Clearance-fitted", "SystemicProcessType": "Hepatic" }, { "Name": "OATP1B1-fitted", "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-fitted", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Miles 1989 - TreatmentPhase - Erythromycin", "Formulations": [ { "Name": "Erythromycin_Weibull_enteric-coated-pellets", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µg/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Miles1989_TreatmentPhase_300mg-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Miles1989_TreatmentPhase_300mg|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } }, { "Name": "Erythromycin-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Miles1989_TreatmentPhase_300mg|Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 2 } } ], "Name": "Miles1989_control_357_md_tabIR", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nMiles1989_TreatmentPhase_300mg\n2022-05-04 10:04" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "Erythromycin" } ] }, { "Name": "Miles1989_TreatmentPhase_357mg", "Model": "4Comp", "ObservedData": [ "Miles 1989 - CBZ during ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 408.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_16|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_17|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg|CBZ_tabletIR_fasted (Tegretol)|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Undefined Liver|Reference concentration", "Value": 1.0, "Unit": "µmol/l" }, { "Path": "Undefined Liver|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "Undefined Liver|t1/2 (liver)", "Value": 36.0, "Unit": "h" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)" ], "Individual": "Miles1989", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Miles 1989 - TreatmentPhase - Carbamazepine 357.1mg", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } }, { "Name": "Erythromycin", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - Charge dependent Schmitt" ], "Alternatives": [ { "AlternativeName": "Erythromycin base enteric coated pellets", "GroupName": "COMPOUND_SOLUBILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Biotransformation_fitted", "MoleculeName": "CYP3A4" }, { "MoleculeName": "CYP2B6" }, { "MoleculeName": "UGT2B7" }, { "Name": "Total Hepatic Clearance-fitted", "SystemicProcessType": "Hepatic" }, { "Name": "OATP1B1-fitted", "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-fitted", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Miles 1989 - TreatmentPhase - Erythromycin", "Formulations": [ { "Name": "Erythromycin_Weibull_enteric-coated-pellets", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µg/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Miles1989_TreatmentPhase_357mg-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Miles1989_TreatmentPhase_357mg|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } }, { "Name": "Erythromycin-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Miles1989_TreatmentPhase_357mg|Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 2 } }, { "Name": "Miles 1989 - CBZ during ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)-Carbamazepine-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Miles 1989 - CBZ during ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|Time", "Y": "Miles 1989 - CBZ during ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Miles1989_control_357_md_tabIR", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nMiles1989_TreatmentPhase_357mg\n2022-05-09 10:47" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "Erythromycin" } ] }, { "Name": "Miles1989_TreatmentPhase_400mg", "Model": "4Comp", "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 384.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 386.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 408.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_16|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_17|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Carbamazepine 400mg|CBZ_tabletIR_fasted (Tegretol)|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Miles 1989 - TreatmentPhase - Erythromycin|Erythromycin_Weibull_enteric-coated-pellets|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Undefined Liver|Reference concentration", "Value": 1.0, "Unit": "µmol/l" }, { "Path": "Undefined Liver|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "Undefined Liver|t1/2 (liver)", "Value": 36.0, "Unit": "h" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)" ], "Individual": "Miles1989", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Miles 1989 - TreatmentPhase - Carbamazepine 400mg", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } }, { "Name": "Erythromycin", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - Charge dependent Schmitt" ], "Alternatives": [ { "AlternativeName": "Erythromycin base enteric coated pellets", "GroupName": "COMPOUND_SOLUBILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Biotransformation_fitted", "MoleculeName": "CYP3A4" }, { "MoleculeName": "CYP2B6" }, { "MoleculeName": "UGT2B7" }, { "Name": "Total Hepatic Clearance-fitted", "SystemicProcessType": "Hepatic" }, { "Name": "OATP1B1-fitted", "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-fitted", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Miles 1989 - TreatmentPhase - Erythromycin", "Formulations": [ { "Name": "Erythromycin_Weibull_enteric-coated-pellets", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µg/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Miles1989_TreatmentPhase_400mg-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Miles1989_TreatmentPhase_400mg|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } }, { "Name": "Erythromycin-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Miles1989_TreatmentPhase_400mg|Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 2 } } ], "Name": "Miles1989_control_357_md_tabIR", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nMiles1989_TreatmentPhase_400mg\n2022-05-09 15:42" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "Erythromycin" } ] }, { "Name": "Wong1983_ControlPhase", "Model": "4Comp", "ObservedData": [ "Wong 1983 - Treatment B (without erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 72.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Barzaghi1987_ControlPhase|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)" ], "Individual": "Wong1983", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Barzaghi1987_ControlPhase", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µg/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Wong1983_ControlPhase-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Wong1983_ControlPhase|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } }, { "Name": "Wong 1983 - Treatment B (without erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.-Carbamazepine-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Wong 1983 - Treatment B (without erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.|Time", "Y": "Wong 1983 - Treatment B (without erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 6, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Wong1983_control_400mg_sd_tabIR", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nWong1983_ControlPhase\n2022-05-09 17:04" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" } ] }, { "Name": "Wong1983_TreatmentPhase", "Model": "4Comp", "ObservedData": [ "Wong 1983 - Treatment A (with erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 8.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 120.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] }, { "Parameters": [ { "Name": "Start time", "Value": 120.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 122.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 122.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 192.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Events|Wong1983_TreatmentPhase_Carbamazepine|CBZ_tabletIR_fasted (Tegretol)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_16|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_17|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_18|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_19|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_20|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_21|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_22|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_23|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_24|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_25|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_26|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_27|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_28|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_29|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_30|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_31|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_32|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Events|Wong1983_TreatmentPhase_Erythromycin|Erythromycin_Weibull_filmtablet_250mg|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Undefined Liver|Reference concentration", "Value": 1.0, "Unit": "µmol/l" }, { "Path": "Undefined Liver|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "Undefined Liver|t1/2 (liver)", "Value": 36.0, "Unit": "h" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)" ], "Individual": "Wong1983", "Compounds": [ { "Name": "Carbamazepine", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "IR tablet (FaHIF)", "GroupName": "COMPOUND_SOLUBILITY" } ], "Processes": [ { "Name": "CYP3A4-Epoxidation_Sakamoto2013", "MoleculeName": "CYP3A4" }, { "Name": "CYP2B6-3-Hydroxylation_Pearce2002", "MoleculeName": "CYP2B6" }, { "Name": "UGT2B7-N-Glucuronidation_Staines2004", "MoleculeName": "UGT2B7" }, { "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-Glomerular Filtration", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Wong1983_TreatmentPhase_Carbamazepine", "Formulations": [ { "Name": "CBZ_tabletIR_fasted (Tegretol)", "Key": "Formulation" } ] } }, { "Name": "Erythromycin", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - Charge dependent Schmitt" ], "Alternatives": [ { "AlternativeName": "Erythromycin stearate film-coated tablet", "GroupName": "COMPOUND_SOLUBILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Biotransformation_fitted", "MoleculeName": "CYP3A4" }, { "MoleculeName": "CYP2B6" }, { "MoleculeName": "UGT2B7" }, { "Name": "Total Hepatic Clearance-fitted", "SystemicProcessType": "Hepatic" }, { "Name": "OATP1B1-fitted", "MoleculeName": "OATP1B1" }, { "Name": "Glomerular Filtration-fitted", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Wong1983_TreatmentPhase_Erythromycin", "Formulations": [ { "Name": "Erythromycin_Weibull_filmtablet_250mg", "Key": "Formulation" } ] } } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µg/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Linear", "NumberMode": "Normal" } ], "Curves": [ { "Name": "Wong1983_TreatmentPhase-Carbamazepine-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Wong1983_TreatmentPhase|Organism|PeripheralVenousBlood|Carbamazepine|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 1 } }, { "Name": "Erythromycin-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "Wong1983_TreatmentPhase|Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 2 } }, { "Name": "Wong 1983 - Treatment A (with erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.-Carbamazepine-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Wong 1983 - Treatment A (with erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.|Time", "Y": "Wong 1983 - Treatment A (with erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Wong1983_control_400mg_sd_tabIR", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "RightInside", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Erythromycin-Carbamazepine-DDI\nWong1983_TreatmentPhase\n2022-05-09 17:07" } ], "Interactions": [ { "Name": "CYP3A4-DMPK", "MoleculeName": "CYP3A4", "CompoundName": "Carbamazepine" }, { "Name": "CYP2B6-Faucette2004", "MoleculeName": "CYP2B6", "CompoundName": "Carbamazepine" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "Erythromycin" } ] } ], "ObservedData": [ { "Name": "Barzaghi 1987 - Without erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 463.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Barzaghi 1987", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/3440106/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1a", "Type": "String" }, { "Name": "Grouping", "Value": "Without erythromycin", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 7.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "400 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": ".", "Type": "String" }, { "Name": "Food state", "Value": "fed", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Barzaghi 1987 - Without erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 236.269 }, "Values": [ 0.6106672, 0.4555764, 0.5137358, 0.5136919, 0.8045733, 0.6785192, 0.6009734, 0.6204029, 0.6397463, 0.5428153 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Barzaghi 1987 - Without erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 236.269 }, "Values": [ 3.693691, 4.94454, 5.119713, 4.801061, 4.000761, 3.49916, 2.825349, 2.459626, 1.92165112, 1.308572 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Barzaghi 1987 - Without erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 2.0, 4.0, 6.0, 10.0, 24.0, 32.0, 48.0, 56.0, 72.0, 96.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Barzaghi 1987 - Without erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 464.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Barzaghi 1987", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/3440106/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1b", "Type": "String" }, { "Name": "Grouping", "Value": "Without erythromycin", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 7.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine-10-11-epoxide", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "400 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": ".", "Type": "String" }, { "Name": "Food state", "Value": "fed", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Barzaghi 1987 - Without erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine-10-11-epoxide|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 252.27 }, "Values": [ 0.0152851595, 0.0178993084, 0.0301285181, 0.03055457, 0.03579338, 0.03186955, 0.04409863, 0.04409866, 0.02751428, 0.02270156 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Barzaghi 1987 - Without erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine-10-11-epoxide|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 252.27 }, "Values": [ 0.03587215, 0.07349583, 0.1036873, 0.1313382, 0.1763829, 0.1928195, 0.158918887, 0.14829351, 0.107833795, 0.07160776 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Barzaghi 1987 - Without erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 2.0, 4.0, 6.0, 10.0, 24.0, 32.0, 48.0, 56.0, 72.0, 96.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Wong 1983 - Treatment B (without erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 1153.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Wong 1983", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6831824/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "Treatment B (without erythromycin)", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "400 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": ".", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Wong 1983 - Treatment B (without erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 236.269 }, "Values": [ 2.271022, 2.394349, 2.795466, 3.58727, 4.063444, 4.315975, 4.315197, 4.169291, 4.059192, 3.678204, 2.864441, 2.585644, 2.083754, 1.777015 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Wong 1983 - Treatment B (without erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.0, 2.0, 4.0, 6.0, 8.0, 12.0, 16.0, 24.0, 30.0, 36.0, 48.0, 54.0, 60.0, 72.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Miles 1989 - CBZ before ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 1418.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Miles 1989", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/2911854/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "CBZ before ERY", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 7.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "300-400; mean dose: 357.1 +/- 53.5 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T24-R14", "Type": "String" }, { "Name": "Formulation", "Value": "200mg tablets - Tegretol, lot no. 1T000470; Ciba-Geigy, Summit, NJ, USA", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Miles 1989 - CBZ before ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 236.269, "LLOQ": 1E-06 }, "Values": [ 5.35977, 6.430851, 6.982509, 7.118526, 7.091334, 6.885978, 6.636095, 6.077072, 5.503095, 5.137022 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Miles 1989 - CBZ before ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 312.0, 314.0, 316.0, 318.0, 320.0, 322.0, 324.0, 328.0, 332.0, 336.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Miles 1989 - CBZE before ERY - Carbamazepine-10-11-epoxide - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 1419.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Miles 1989", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/2911854/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "CBZE before ERY", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 7.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine-10-11-epoxide", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "300-400; mean dose: 357.1 +/- 53.5 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T24-R14", "Type": "String" }, { "Name": "Formulation", "Value": "200mg tablets - Tegretol, lot no. 1T000470; Ciba-Geigy, Summit, NJ, USA", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Miles 1989 - CBZE before ERY - Carbamazepine-10-11-epoxide - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine-10-11-epoxide|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 252.27, "LLOQ": 5E-07 }, "Values": [ 1.010919, 1.072781, 1.075274, 1.092552, 1.139515, 1.186478, 1.174128, 1.13453, 1.094988, 1.040547 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Miles 1989 - CBZE before ERY - Carbamazepine-10-11-epoxide - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 312.0, 314.0, 316.0, 318.0, 320.0, 322.0, 324.0, 328.0, 332.0, 336.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Barzaghi 1987 - With erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 465.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Barzaghi 1987", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/3440106/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1a", "Type": "String" }, { "Name": "Grouping", "Value": "With erythromycin", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 7.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "400 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 144.0, "Type": "Double" }, { "Name": "Formulation", "Value": ".", "Type": "String" }, { "Name": "Food state", "Value": "fed", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Barzaghi 1987 - With erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 236.269 }, "Values": [ 0.5039988, 0.3684254, 0.562202, 0.6591768, 0.5621142, 0.5331213, 0.6009293, 0.6591327, 0.6881251, 0.5912805 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Barzaghi 1987 - With erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 236.269 }, "Values": [ 4.313876, 4.789536, 4.974317, 4.762289, 4.407915, 3.78991, 3.406981, 2.944239, 2.522624, 1.812527 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Barzaghi 1987 - With erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 146.0, 148.0, 150.0, 154.0, 168.0, 176.0, 192.0, 200.0, 216.0, 240.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Barzaghi 1987 - With erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 466.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Barzaghi 1987", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/3440106/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1b", "Type": "String" }, { "Name": "Grouping", "Value": "With erythromycin", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 7.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine-10-11-epoxide", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "400 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 144.0, "Type": "Double" }, { "Name": "Formulation", "Value": ".", "Type": "String" }, { "Name": "Food state", "Value": "fed", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Barzaghi 1987 - With erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine-10-11-epoxide|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 252.27 }, "Values": [ 0.007858234, 0.009604511, 0.008736618, 0.0117873494, 0.01877245, 0.02314342, 0.0165843386, 0.01572697, 0.01571121, 0.0139754489 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Barzaghi 1987 - With erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine-10-11-epoxide|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 252.27 }, "Values": [ 0.01709445, 0.03070686, 0.0434408672, 0.05799469, 0.09954158, 0.101582006, 0.1017231, 0.08630075, 0.08075599, 0.06025172 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Barzaghi 1987 - With erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 146.0, 148.0, 150.0, 154.0, 168.0, 176.0, 192.0, 200.0, 216.0, 240.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Miles 1989 - CBZ during ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 1420.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Miles 1989", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/2911854/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "CBZ during ERY", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 7.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "300-400; mean dose: 357.1 +/- 53.5 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T24-R17", "Type": "String" }, { "Name": "Formulation", "Value": "200mg tablets - Tegretol, lot no. 1T000470; Ciba-Geigy, Summit, NJ, USA", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Miles 1989 - CBZ during ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 236.269, "LLOQ": 1E-06 }, "Values": [ 5.241032, 6.653486, 6.982566, 7.177952, 7.106176, 6.796924, 6.829101, 6.388704, 5.85931, 5.582291 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Miles 1989 - CBZ during ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 384.0, 386.0, 388.0, 390.0, 392.0, 394.0, 396.0, 400.0, 404.0, 408.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Miles 1989 - CBZE during ERY - Carbamazepine-10-11-epoxide - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 1421.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Miles 1989", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/2911854/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "CBZE during ERY", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 7.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine-10-11-epoxide", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "300-400; mean dose: 357.1 +/- 53.5 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T24-R17", "Type": "String" }, { "Name": "Formulation", "Value": "200mg tablets - Tegretol, lot no. 1T000470; Ciba-Geigy, Summit, NJ, USA", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Miles 1989 - CBZE during ERY - Carbamazepine-10-11-epoxide - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine-10-11-epoxide|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 252.27, "LLOQ": 5E-07 }, "Values": [ 0.8328117, 0.8501466, 0.8674815, 0.8550751, 0.8575111, 0.859947, 0.8772819, 0.8525259, 0.8426688, 0.8178561 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Miles 1989 - CBZE during ERY - Carbamazepine-10-11-epoxide - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 384.0, 386.0, 388.0, 390.0, 392.0, 394.0, 396.0, 400.0, 404.0, 408.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Wong 1983 - Treatment A (with erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 1154.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Wong 1983", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6831824/", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "Treatment A (with erythromycin)", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Carbamazepine", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "400 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 120.0, "Type": "Double" }, { "Name": "Formulation", "Value": ".", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Wong 1983 - Treatment A (with erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Carbamazepine|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 236.269 }, "Values": [ 2.035254, 2.572669, 3.301302, 3.89834571, 4.834243, 4.724909, 4.075684, 4.704001, 4.246293, 3.486601, 3.171208, 3.018359, 2.52562 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Wong 1983 - Treatment A (with erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 121.0, 122.0, 124.0, 126.0, 132.0, 136.0, 144.0, 150.0, 156.0, 168.0, 174.0, 180.0, 192.0 ], "Dimension": "Time", "Unit": "h" } } ], "ObservedDataClassifications": [ { "Name": "Wong 1983", "Classifiables": [ "Wong 1983 - Treatment B (without erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv.", "Wong 1983 - Treatment A (with erythromycin) - Carbamazepine - PO - 400 mg - Plasma - indiv." ] }, { "Name": "Miles 1989", "Classifiables": [ "Miles 1989 - CBZ before ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)", "Miles 1989 - CBZE before ERY - Carbamazepine-10-11-epoxide - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)", "Miles 1989 - CBZ during ERY - Carbamazepine - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)", "Miles 1989 - CBZE during ERY - Carbamazepine-10-11-epoxide - PO - 300-400; mean dose: 357.1 +/- 53.5 mg - Serum - agg. (n=7)" ] }, { "Name": "Barzaghi 1987", "Classifiables": [ "Barzaghi 1987 - Without erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)", "Barzaghi 1987 - Without erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)", "Barzaghi 1987 - With erythromycin - Carbamazepine - PO - 400 mg - Serum - agg. (n=7)", "Barzaghi 1987 - With erythromycin - Carbamazepine-10-11-epoxide - PO - 400 mg - Serum - agg. (n=7)" ] } ] }